Céline Auzanneau is an expert in Oncology at Institut Bergonié (France). Céline Auzanneau has authored 29 publications, the most recent in 2022. SLR score: 73 (community average: 125). How the SLR is computed.

LeadR Profile

Céline Auzanneau Institut Bergonié France
73 ScienceLeadR Reputation 73
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2023

Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 29

Citations

Citations: 711 1st author: 5 Last author: 0 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors.
PMID 35850444 — plasma, biomarkers, cells, therapeutics, neoplasms, t-lymphocytes, disease-free survival, arginine, progression-free survival, immune checkpoint inhibitors
Ann Oncol Top journal202246
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial.
PMID 34998048 — biliary tract neoplasms, neoplasms, biliary tract, therapeutics
Eur J Cancer202235
Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial.
PMID 33495314 — cells, colorectal neoplasms, microsatellite repeats, disease-free survival, progression-free survival, tumor-associated macrophages
Clin Cancer Res2021115
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
PMID 34740331 — sarcoma, therapeutics, neoplasms, tissues, exome, high-throughput nucleotide sequencing
BMC Cancer202117
Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan.
PMID 32713836 — pilot projects, pilots, workflow, neoplasms, sarcoma, genomic medicine
ESMO Open20209

LeadR Networks

Main global connection map